Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 3 months ago
Duration: 0h 5m 19s
Chinese API price surge tests India's pharma buffers amid West Asia crisis
India's pharmaceutical industry is experiencing increased bulk drug prices, particularly for APIs from China, following the escalation of the West Asia crisis in March. While current inventories provide a temporary buffer, concerns are mounting over the availability of key solvents and feedstocks, potentially leading to manufacturing disruptions and shortages in specific drug categories.
Uploaded by: Rediff Video Desk on Sat, 02 May 2026 14:32:09 +0530
Views: 40
Tags: India, API, China, DoP, MIP, Paracetamol, KSM, PLI, Department of Pharmaceuticals, Business Standard
